1 year return (CAGR)
679.20%
Reata Pharmaceuticals Inc Exchange (NASDAQ, USD)
RETA
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
16.64%
5 year return (CAGR)
14.51%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
5.79B
Price/Sales
237.31
Ent value
6.16B
Price/Book
66.32
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
33.94%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 172.36 |
| Daily high | 172.36 |
| Daily low | 172.36 |
| Daily Volume | 0K |
| 1y analyst estimate | 172.40 |
| Beta | 1.42 |
| EPS (TTM) | -1.93 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| RETA | S&P500 | |
| Current price drop from All-time high | -30.43% | -10.85% |
| Highest price drop | -92.20% | -56.47% |
| Date of highest drop | 17 Aug 2022 | 9 Mar 2009 |
| Avg drop from high | -40.88% | -10.68% |
| Avg time to new high | 30 days | 12 days |
| Max time to new high | 918 days | 1805 days |
News
No items found